We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA SEEKS BIOEQUIVALENCE DATA TO ASSESS CHANGES
FDA SEEKS BIOEQUIVALENCE DATA TO ASSESS CHANGES
January 5, 2004
The FDA is proposing to require manufacturers to submit data from all bioequivalence studies in abbreviated new drug application (ANDA) amendments and supplements to applications.